Results 121 to 130 of about 19,815 (203)

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. [PDF]

open access: yes, 1995
To determine the functional importance of Ras in transformation by Abl oncogenes, we used a genetic approach to measure the effect of impaired Ras activity on the ability of Bcr-Abl or v-Abl to transform cells.
McLaughlin, J, Sawyers, CL, Witte, ON
core  

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Молекулярно-генетическая диагностика минимальной остаточной болезни в онкогематологии [PDF]

open access: yes, 2014
лейкозГЕМАТОЛОГИЧЕСКИЕ НОВООБРАЗОВАНИЯГЕННАЯ ЭКСПРЕССИЯГЕНЕТИЧЕСКИЕ ...
Семенов, В. М.   +1 more
core  

Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.

open access: yesHaematologica, 2000
Although bcr-abl polymerase chain reaction (PCR) positivity after bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) is significantly related to relapse, the predictive value of the assay is not very high and therefore most investigators consider that qualitative RT-PCR data alone are too imprecise to enable clinical decisions to ...
J, Román   +10 more
openaire   +1 more source

Analysis of imatinib in bone marrow and plasma samples of chronic myeloid leukaemia patients using solid phase extraction LC-ESI-MS [PDF]

open access: yes, 2011
The LC-ESI-MS was developed and validated for the analysis of imatinib in plasma and bone marrow samples using deuterated imatinib (D(8)-IM) as an internal standard. The biological samples were extracted using Strata-X-C SPE cartridges and separated on C&
Elliott, M.   +4 more
core   +1 more source

New prognostic factors in chronic myeloid leukaemia

open access: yes, 2010
The tyrosine kinase inhibitor imatinib mesylate (IM) has proved a major advance in the management of patients with chronic myeloid leukaemia (CML) but about 15% of patients do not achieve complete cytogenetic responses (CCyR) (primary resistance) and a ...
Khorashad, Sorouri, Khorashad, Sorouri
core   +1 more source

Cromossoma Philadelphia e leucemia : biologia e terapêutica [PDF]

open access: yes, 2016
Monografia realizada no âmbito da unidade de Estágio Curricular do Mestrado Integrado em Ciências Farmacêuticas, apresentada à Faculdade de Farmácia da Universidade de CoimbraA Leucemia Mielóide Crónica (LMC) é uma neoplasia caraterizada por uma ...
Martins, Sofia Vanessa Rodrigues
core  

Home - About - Disclaimer - Privacy